A study published in The New England Journal of Medicine revealed the benefits of Lilly's MOUNJARO (tirzepatide) over Novo Nordisk's WEGOVY (semaglutide). …
Latest Video
New Stories
-
Health stakeholders welcome the reappointment of Mark Butler
May 12, 2025 - - Latest News -
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 - - Latest News -
Lilly touts weight management results in new head-to-head study
May 12, 2025 - - Latest News -
Experienced industry executive appointed chair of Tryptamine Therapeutics
May 12, 2025 - - Australian Biotech -
Monash scientists secure MRFF funding to find new medicines for dementia by 'lighting up' human brain cells
May 12, 2025 - -
Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial
May 12, 2025 - - Australian Biotech -
An already busy fixed ministerial bandwidth, just got much busier
May 12, 2025 - - Latest News